Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors
Authors:
- Hans WallbergHWHans Wallberg
- Lotta VrangLVLotta Vrang
- Stefan OscarsonSOStefan Oscarson
- Kevin ParkesKPKevin Parkes
- Anders HallbergAHAnders Hallberg
- Bertil SamuelssonBSBertil Samuelsson
- 1 January 2010
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (1) , 160-170
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical StrainsJournal of Molecular Biology, 2004
- Bis(2-methoxyethyl)aminosulfur trifluoride: a new broad-spectrum deoxofluorinating agent with enhanced thermal stabilityChemical Communications, 1999
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Mapping the Aspartic Acid Binding Site of Escherichia coli Asparagine Synthetase B Using Substrate AnalogsJournal of Medicinal Chemistry, 1996
- Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl)amino]zinc Ligand: Modification of the P1 and P2' ResiduesJournal of Medicinal Chemistry, 1994
- Structure‐toxicity relationships in the amatoxin seriesInternational Journal of Peptide and Protein Research, 1992
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- Perkin communications. Asymmetric amino acid synthesis: preparation of the ? anion derived from aspartic acidJournal of the Chemical Society, Perkin Transactions 1, 1989
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Über Steroide und Sexualhormone. Synthese eines digitaloiden Aglykons mit dem Kern der CholsäureHelvetica Chimica Acta, 1947